$14M sweet spot round size
Most of their 25 investments are in rounds between $4.2M and $23M
2015
Octave Bioscience raised $30M on July 26, 2023
Investors: Section 32, Northpond Ventures, Casdin Capital, LLC, Intermountain Ventures, ECHO and Hikma Ventures
Prognos Health raised $23M on May 4, 2023
Investors: Red & Blue Ventures, Labcorp, MAYWIC Select Investments, Marshall Wace, Safeguard Scientifics and Hikma Ventures
O7 Therapy raised $2.1M on April 4, 2022
Investors: C Ventures and Hikma Ventures
Altoida, Inc. raised $14M on March 30, 2022
Investors: FYRFLY Venture Partners, Whitecap Venture Partners, M Ventures, Alpana Ventures SA, b-to-v Partners AG, VI Partners AG and Hikma Ventures
Altibbi raised $44M on March 28, 2022
Investors: Global Ventures, DASH Ventures Ltd., Foundation Holdings and Hikma Ventures
Activ Surgical raised $15M on March 22, 2022
Investors: MINT Venture Partners, Alumni Ventures Group and Hikma Ventures
Undisclosed raised $11M on January 19, 2022
Investors: Hikma Ventures
BioSapien raised $1.8M on November 11, 2021
Investors: Side Door Ventures, SOSV - The Accelerator VC, George and Saul, -, Harbr and Hikma Ventures
Biolinq raised $100M on November 2, 2021
Investors: The Broe Group, RiverVest Venture Partners, Global Health Funds, JDRF T1D Fund, M Ventures, Longevity Vision Fund and Hikma Ventures
Click Therapeutics, Inc. raised $52M on October 22, 2021
Investors: Sanofi Ventures, H.I.G. BioVentures, Revelation Partners, K2 HealthVentures, Accelmed, Health Catalyst Capital Management LLC and Hikma Ventures